Pierluigi Paracchi

Co-Founder and CEO of Genenta Science. He discusses the company's cell therapy and recent funding.

Best podcasts with Pierluigi Paracchi

Ranked by the Snipd community

May 6, 2025 • 9min

Swiss Biotech Day: Milan based Genenta Science recently raised €20 million from a government investment fund as it takes its cell therapy into the clinic in renal cell carcinoma

Pierluigi Paracchi, Co-Founder and CEO of Genenta Science, shares insights on the company's groundbreaking cell therapy approach for renal cell carcinoma. He explains the recent €20 million funding from ENEA Tech and Biomedical, highlighting the innovative convertible bond structure. Paracchi updates listeners on clinical trials and the exciting prospects for patient dosing, emphasizing the challenges and opportunities within the European biotech landscape. The conversation also touches on the impact of this investment on Genenta's future and advancements in the broader field of cancer therapy.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

App store banner

Play store banner